These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structural basis and mechanism of enoyl reductase inhibition by triclosan. Stewart MJ; Parikh S; Xiao G; Tonge PJ; Kisker C J Mol Biol; 1999 Jul; 290(4):859-65. PubMed ID: 10398587 [TBL] [Abstract][Full Text] [Related]
6. Signature gene expression profile of triclosan-resistant Escherichia coli. Yu BJ; Kim JA; Pan JG J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062 [TBL] [Abstract][Full Text] [Related]
7. Molecular basis for triclosan activity involves a flipping loop in the active site. Qiu X; Janson CA; Court RI; Smyth MG; Payne DJ; Abdel-Meguid SS Protein Sci; 1999 Nov; 8(11):2529-32. PubMed ID: 10595560 [TBL] [Abstract][Full Text] [Related]
8. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus. Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562 [TBL] [Abstract][Full Text] [Related]
9. Kinetic determinants of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Kapoor M; Dar MJ; Surolia A; Surolia N Biochem Biophys Res Commun; 2001 Dec; 289(4):832-7. PubMed ID: 11735121 [TBL] [Abstract][Full Text] [Related]
10. Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan. Priyadarshi A; Kim EE; Hwang KY Proteins; 2010 Feb; 78(2):480-6. PubMed ID: 19768684 [No Abstract] [Full Text] [Related]
11. A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase. Levy CW; Baldock C; Wallace AJ; Sedelnikova S; Viner RC; Clough JM; Stuitje AR; Slabas AR; Rice DW; Rafferty JB J Mol Biol; 2001 May; 309(1):171-80. PubMed ID: 11491286 [TBL] [Abstract][Full Text] [Related]
12. X-ray crystallographic analysis of the complexes of enoyl acyl carrier protein reductase of Plasmodium falciparum with triclosan variants to elucidate the importance of different functional groups in enzyme inhibition. Maity K; Bhargav SP; Sankaran B; Surolia N; Surolia A; Suguna K IUBMB Life; 2010 Jun; 62(6):467-76. PubMed ID: 20503440 [TBL] [Abstract][Full Text] [Related]
13. Enoyl-ACP reductase (FabI) of Haemophilus influenzae: steady-state kinetic mechanism and inhibition by triclosan and hexachlorophene. Marcinkeviciene J; Jiang W; Kopcho LM; Locke G; Luo Y; Copeland RA Arch Biochem Biophys; 2001 Jun; 390(1):101-8. PubMed ID: 11368521 [TBL] [Abstract][Full Text] [Related]
14. Kinetic and structural characteristics of the inhibition of enoyl (acyl carrier protein) reductase by triclosan. Ward WH; Holdgate GA; Rowsell S; McLean EG; Pauptit RA; Clayton E; Nichols WW; Colls JG; Minshull CA; Jude DA; Mistry A; Timms D; Camble R; Hales NJ; Britton CJ; Taylor IW Biochemistry; 1999 Sep; 38(38):12514-25. PubMed ID: 10493822 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Pseudomonas aeruginosa enoyl-acyl carrier protein reductase (FabI): a target for the antimicrobial triclosan and its role in acylated homoserine lactone synthesis. Hoang TT; Schweizer HP J Bacteriol; 1999 Sep; 181(17):5489-97. PubMed ID: 10464225 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs. Sivaraman S; Zwahlen J; Bell AF; Hedstrom L; Tonge PJ Biochemistry; 2003 Apr; 42(15):4406-13. PubMed ID: 12693936 [TBL] [Abstract][Full Text] [Related]
19. Exploring the interaction energies for the binding of hydroxydiphenyl ethers to enoyl-acyl carrier protein reductases. Muralidharan J; Suguna K; Surolia A; Surolia N J Biomol Struct Dyn; 2003 Feb; 20(4):589-94. PubMed ID: 12529157 [TBL] [Abstract][Full Text] [Related]